Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06941545 · ClinicalTrials.gov registry record · NA
High Resolution Gastric Mapping and Gastroduodenal Manometry
A NA study of Dyspepsia, sponsored by Mayo Clinic.
- Recruiting
- Registry status
- NA
- Development phase
- 100
- Enrollment target
- 1
- Study location
NCT06941545: Recruiting NA study of Dyspepsia, sponsored by Mayo Clinic.
NCT06941545 is a NA study of Dyspepsia that is actively recruiting participants, run by Mayo Clinic. The registered enrollment target is 100 participants, above the 68-participant average among 11 other Dyspepsia trials with a reported enrollment target (47% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06941545, a NA study of Dyspepsia, is actively recruiting participants, sponsored by Mayo Clinic.
- RECRUITING
- Registry status
- NA
- Development phase
- 100 participants
- Enrollment target
- 1
- Study location
Study Summary
Dyspepsia is a common problem attributed to gastric sensorimotor dysfunctions ie, delayed, or less frequently rapid gastric emptying (GE), impaired gastric accommodation, and increased gastric sensation. Therapeutic options manage symptoms, and there is no FDA approved medical therapy for dyspepsia. There is a need for better objective understanding of sensorimotor dysfunction in dyspepsia, as well as noninvasive, efficacious, safe, and inexpensive treatments for dyspepsia. The purpose of this research is to identify disturbances and characterize phenotypes in patients with functional dyspepsia, and to assess the correlations between symptoms (during the manometry and in daily life), gastric emptying, electrical activity (BSGM), and pressure activity (manometry).
Primary Outcome
Summarized as frequency (number of contractions per minute)
Conditions Studied
Interventions
- DEVICE Alimetry
- DEVICE tVNS
- DEVICE Gastroduodenal Manometry
Study Locations (1)
Minnesota
- Mayo Clinic in Rochester - Rochester
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 100 participants |
| Start Date | 2025-07-11 |
| Est. Completion | 2026-12-31 |
| Phase | NA |
What NCT06941545 shows while recruiting
NCT06941545 is an interventional study that assigns participants to a tested intervention. The registered 100 participants enrollment target is mid-sized for trials with a published cap, above the 68-participant average among 11 other Dyspepsia trials with a reported enrollment target (47% higher).
The record links to 1 condition, with Dyspepsia appearing as the primary indexed condition, and to 3 interventions - of which Alimetry is the first listed.
NCT06941545 reports a single indexed study location in Minnesota.
Frequently Asked Questions
What is clinical trial NCT06941545 about?
NCT06941545 is a clinical study titled "High Resolution Gastric Mapping and Gastroduodenal Manometry". Dyspepsia is a common problem attributed to gastric sensorimotor dysfunctions ie, delayed, or less frequently rapid gastric emptying (GE), impaired gastric accommodation, and increased gastric sensation. Therapeutic options manage symptoms, and there is no FDA approved medical therapy for dyspepsia....
What is the current status of trial NCT06941545?
This trial is currently recruiting. It is a NA study. The enrollment target is 100 participants. The study started on 2025-07-11. Estimated completion is 2026-12-31.
What conditions does trial NCT06941545 study?
This clinical trial studies the following conditions: Dyspepsia.
What interventions are being tested in trial NCT06941545?
The interventions under investigation include: Alimetry (DEVICE), tVNS (DEVICE), Gastroduodenal Manometry (DEVICE).
Who is sponsoring clinical trial NCT06941545?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06941545 being conducted?
This trial has 1 study location across Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Dyspepsia
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06941545's enrollment target sits among peer trials
100 2nd of 11 higher than 9 of 11 other Dyspepsia trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Dyspepsia trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Visible Abdominal Distension
RECRUITING · NA
-
Zypan Functional Dyspepsia
RECRUITING · NA
-
Exposure-Based CBT for Avoidant/Restrictive Food Intake in Functional Dyspepsia
RECRUITING · NA
-
Vagal Nerve Stimulation for Functional Dyspepsia and Gastroparesis
RECRUITING · NA
-
Magnetically Controlled Capsule Endoscopy Feasibility Study in Gastric Motility
ACTIVE NOT RECRUITING · NA
-
Melatonin in Pediatric FD Population
COMPLETED · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01048281 · 100 participants
Clinical & Pathological Studies of Upper Gastrointestinal Carcinoma
- NCT01161199 · 100 participants
The Use of Leukapheresis to Support HIV Pathogenesis Studies
- NCT01327690 · 100 participants · Early Phase 1
Mental Health in Veterans and Families After Group Therapies
- NCT01730781 · 100 participants
Imaging Cannabinoid Receptors Using Positron Emission Tomography (PET) Scanning
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI